Capsaicin Patch (Qutenza) for Postherpetic Neuralgia
Capsaicin Patch (Qutenza) for Postherpetic Neuralgia
May 30, 2011 (Issue: 1365)
The FDA has approved a topical 8% patch formulation
of capsaicin (Qutenza – NeurogesX), available only by
prescription, for local treatment of postherpetic neuralgia.
Postherpetic neuralgia occurs after herpes zoster
in about one third of...more
1. Herpes zoster vaccine (Zostavax). Med Lett Drugs Ther 2006; 48: 73.
2. Drugs for pain. Treat Guidel Med Lett 2010; 8:25.
3. MM Backonja et al. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind controlled study with an open-label extension. Pain Med 2010; 11:600.
4. GA Irving et al. A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. Pain Med 2011; 12:99.
5. PL McCormack. Capsaicin dermal patch: in non-diabetic peripheral neuropathic pain. Drugs 2010; 70:1831.
6. DM Simpson et al. Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain. J Pain Symptom Manage 2010; 39:1053.
7. Cost of one 0.8% capsaicin patch and 50-gram tube of cleansing gel according to Red Book Update July 2010.
8. Cost according to drugstore.com. Accessed May 10, 2011.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this article? Gain access below.
Subscribe
Subscriptions to
The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App
- FREE online per issue CME/CE
Purchase this article:
Title: Capsaicin Patch (Qutenza) for Postherpetic Neuralgia
Article code: 1365c
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
